论文信息 - Efficacy and Safety 48 Weeks after Switching from Efavirenz to Rilpivirine Using Emtricitabine/Tenofovir Disoproxil Fumarate–Based Single-Tablet Regimens - 字舞流文

Efficacy and Safety 48 Weeks after Switching from Efavirenz to Rilpivirine Using Emtricitabine/Tenofovir Disoproxil Fumarate–Based Single-Tablet Regimens

K. White | C. Cohen | A. Cheng | E. Dejesus | S. Ramanathan | A. Mills | C. Brinson | Kitty Yale | S. Chuck | Maggie Wang | S. Williams